We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sound Processor Helps the Deaf Adapt to Different Sound Settings

By HospiMedica International staff writers
Posted on 20 Jul 2009
A programmable bone conduction hearing system allows the hearing impaired easy transition between different listening environments, without degradation in hearing performance.

The Cochlear Bone-Anchored Hearing Aid (BAHA) BP100 Sound Processor is intended for children and adults with conductive hearing loss, mixed hearing loss, or single-sided sensorineural deafness. More...
The bone-anchored hearing solution has advanced automatic digital signal processing functions that automatically adapt to the user's sound environment, helping to provide greater audibility and listening comfort across different listening environments. The system also incorporates features especially designed for children, including tamper-resistant battery doors, a key lock function, and a titanium and plastic casing for maximum durability. The device is designed with improved water protection, allowing children and adults to live full, active lives. For clinicians, the proprietary cochlear fitting software and three distinct fitting options provide increased flexibility, offering better fitting precision. The Cochlear BAHA BP100 Sound Processor is a product of Cochlear (Lane Cove, NSW, Australia).

"The BAHA BP100 is the most advanced implantable bone conduction solution available, representing a major technological leap forward in sound processor utility and design. It's engineered to deliver better hearing performance than ever before,” said Chris Smith, President of Cochlear Americas. "Users who cannot benefit from hearing aids now have the best opportunity to connect to sound and effectively communicate.”

A BAHA is a type of hearing aid based on bone conduction, using a surgically implanted abutment to transmit sound by direct conduction through bone to the inner ear, bypassing the external auditory canal and middle ear. A titanium post is surgically embedded into the skull with a small abutment exposed outside the skin. The sound processor sits on this abutment, transmitting sound vibrations to the titanium implant. The implant then vibrates the skull and inner ear, which stimulate the nerve fibers of the inner ear, allowing hearing. The titanium fixture bonds with the surrounding tissue via osseointegration, and the hearing aid can be used once osseointegration is complete, usually two to six months after implantation.

Related Links:

Cochlear




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.